Literature DB >> 26338180

Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.

Ji-In Bang1, Seunggyun Ha1, Sung-Bum Kang2, Keun-Wook Lee3, Hye-Seung Lee4, Jae-Sung Kim5, Heung-Kwon Oh2, Ho-Young Lee6,7, Sang Eun Kim1.   

Abstract

PURPOSE: The aim of this study was to investigate metabolic and textural parameters from pretreatment [(18)F]FDG PET/CT scans for the prediction of neoadjuvant radiation chemotherapy response and 3-year disease-free survival (DFS) in patients with locally advanced rectal cancer (LARC).
METHODS: We performed a retrospective review of 74 patients diagnosed with LARC who were initially examined with [(18)F]FDG PET/CT, and who underwent neoadjuvant radiation chemotherapy followed by complete resection. The standardized uptake value (mean, peak, and maximum), metabolic volume (MV), and total lesion glycolysis of rectal cancer lesions were calculated using the isocontour method with various thresholds. Using three-dimensional textural analysis, about 50 textural features were calculated for PET images. Response to neoadjuvant radiation chemotherapy, as assessed by histological tumour regression grading (TRG) after surgery and 3-year DFS, was evaluated using univariate/multivariate binary logistic regression and univariate/multivariate Cox regression analyses.
RESULTS: MVs calculated using the thresholds mean standardized uptake value of the liver + two standard deviations (SDs), and mean standard uptake of the liver + three SDs were significantly associated with TRG. Textural parameters from histogram-based and co-occurrence analysis were significantly associated with TRG. However, multivariate analysis revealed that none of these parameters had any significance. On the other hand, MV calculated using various thresholds was significantly associated with 3-year DFS, and MV calculated using a higher threshold tended to be more strongly associated with 3-year DFS. In addition, textural parameters including kurtosis of the absolute gradient (GrKurtosis) were significantly associated with 3-year DFS. Multivariate analysis revealed that GrKurtosis could be a prognostic factor for 3-year DFS.
CONCLUSION: Metabolic and textural parameters from initial [(18)F]FDG PET/CT scans could be indexes to assess tumour heterogeneity for the prediction of neoadjuvant radiation chemotherapy response and recurrence in LARC.

Entities:  

Keywords:  18F-Fluorodeoxyglucose; Metabolic volume; Positron-emission tomography; Prognostic parameter; Tumour heterogeneity; Tumour stage

Mesh:

Substances:

Year:  2015        PMID: 26338180     DOI: 10.1007/s00259-015-3180-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  33 in total

1.  A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision.

Authors:  Julio García-Aguilar; Enrique Hernandez de Anda; Prayuth Sirivongs; Suk-Hwan Lee; Robert D Madoff; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

2.  Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.

Authors:  N A Janjan; V S Khoo; J Abbruzzese; R Pazdur; R Dubrow; K R Cleary; P K Allen; P M Lynch; G Glober; R Wolff; T A Rich; J Skibber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

3.  Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

Authors:  Claus Rödel; Peter Martus; Thomas Papadoupolos; Laszlo Füzesi; Martin Klimpfinger; Rainer Fietkau; Torsten Liersch; Werner Hohenberger; Rudolf Raab; Rolf Sauer; Christian Wittekind
Journal:  J Clin Oncol       Date:  2005-10-24       Impact factor: 44.544

4.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

5.  18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.

Authors:  Felipe A Calvo; Marta Domper; Raúl Matute; Raúl Martínez-Lázaro; José A Arranz; Manuel Desco; Emilio Alvarez; José Luis Carreras
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

6.  The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Authors:  Angela van Baardwijk; Christophe Dooms; Robert Jan van Suylen; Erik Verbeken; Monique Hochstenbag; Cary Dehing-Oberije; Dennis Rupa; Silvia Pastorekova; Sigrid Stroobants; Ulrich Buell; Philippe Lambin; Johan Vansteenkiste; Dirk De Ruysscher
Journal:  Eur J Cancer       Date:  2007-05-23       Impact factor: 9.162

7.  2-Deoxy-2-[18F] fluoro-D-glucose uptake and correlation to intratumoral heterogeneity.

Authors:  Eva Henriksson; Elisabeth Kjellen; Peter Wahlberg; Tomas Ohlsson; Johan Wennerberg; Eva Brun
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

8.  Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.

Authors:  Jose G Guillem; Harvey G Moore; Timothy Akhurst; David S Klimstra; Leyo Ruo; Madhu Mazumdar; Bruce D Minsky; Leonard Saltz; W Douglas Wong; Steven Larson
Journal:  J Am Coll Surg       Date:  2004-07       Impact factor: 6.113

9.  Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Authors:  Carlo Capirci; Lucia Rampin; Paola A Erba; Fabrizio Galeotti; Giorgio Crepaldi; Elena Banti; Marcello Gava; Stefano Fanti; Giuliano Mariani; Pier Carlo Muzzio; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-15       Impact factor: 9.236

10.  FDG-PET. A possible prognostic factor in head and neck cancer.

Authors:  W Halfpenny; S F Hain; L Biassoni; M N Maisey; J A Sherman; M McGurk
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

View more
  25 in total

1.  Perspectives in Radiomics for Personalized Medicine and Theranostics.

Authors:  Seunggyun Ha
Journal:  Nucl Med Mol Imaging       Date:  2019-01-23

2.  Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Kenta Miwa; Kensuke Otani; Tomomichi Kiyomatsu; Hideaki Yano
Journal:  Ann Nucl Med       Date:  2021-05-04       Impact factor: 2.668

Review 3.  Radiomics in Oncological PET/CT: Clinical Applications.

Authors:  Jeong Won Lee; Sang Mi Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-10-20

Review 4.  Characterization of PET/CT images using texture analysis: the past, the present… any future?

Authors:  Mathieu Hatt; Florent Tixier; Larry Pierce; Paul E Kinahan; Catherine Cheze Le Rest; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-06       Impact factor: 9.236

5.  FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.

Authors:  Pierre Lovinfosse; Marc Polus; Daniel Van Daele; Philippe Martinive; Frédéric Daenen; Mathieu Hatt; Dimitris Visvikis; Benjamin Koopmansch; Frédéric Lambert; Carla Coimbra; Laurence Seidel; Adelin Albert; Philippe Delvenne; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-18       Impact factor: 9.236

6.  Comparison of Contrast-Enhanced CT and [18F]FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer.

Authors:  Franca Wagner; Yahya Ali Hakami; Geoffrey Warnock; Gabriel Fischer; Martin W Huellner; Patrick Veit-Haibach
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

7.  Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.

Authors:  Iram Shahzadi; Alex Zwanenburg; Annika Lattermann; Annett Linge; Christian Baldus; Jan C Peeken; Stephanie E Combs; Markus Diefenhardt; Claus Rödel; Simon Kirste; Anca-Ligia Grosu; Michael Baumann; Mechthild Krause; Esther G C Troost; Steffen Löck
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

8.  (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.

Authors:  Pierre Lovinfosse; Benjamin Koopmansch; Frederic Lambert; Sébastien Jodogne; Gaelle Kustermans; Mathieu Hatt; Dimitris Visvikis; Laurence Seidel; Marc Polus; Adelin Albert; Philippe Delvenne; Roland Hustinx
Journal:  Br J Radiol       Date:  2016-05-05       Impact factor: 3.039

Review 9.  Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment.

Authors:  Nina J Wesdorp; Tessa Hellingman; Elise P Jansma; Jan-Hein T M van Waesberghe; Ronald Boellaard; Cornelis J A Punt; Joost Huiskens; Geert Kazemier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-16       Impact factor: 9.236

10.  Prognostic value of metabolic parameters on 18F-fluorodeoxyglucose positron tomography/computed tomography in classical rectal adenocarcinoma.

Authors:  Byung Wook Choi; Sungmin Kang; Sung Uk Bae; Woon Kyung Jeong; Seong Kyu Baek; Bong-Il Song; Kyoung Sook Won; Hae Won Kim
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.